Cost analysis of patients undergoing allogeneic stem cell transplantation or chimeric antigen receptor T-cell therapy in relapsed or refractory diffuse large B-cell lymphoma from a German healthcare payer perspective

Bibliographical data

Original languageEnglish
ISSN0268-3369
DOIs
Publication statusPublished - 04.2024
PubMed 38321270